INTEGRA LIFESCIENCES HOLDINGS CORP Accretion Expense
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Accretion Expense of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2023-02-22
- INTEGRA LIFESCIENCES HOLDINGS CORP accretion expense for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP accretion expense for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP accretion expense for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP accretion expense for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP accretion expense for fiscal 2022 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP accretion expense for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- INTEGRA LIFESCIENCES HOLDINGS CORP accretion expense for fiscal 2020 was $15.41M.
- INTEGRA LIFESCIENCES HOLDINGS CORP accretion expense for fiscal 2019 was $0.00.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-22 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $0.00 derived: sum of 2 quarters · filed 2023-02-22 | $0.00 derived: sum of 3 quarters · filed 2023-02-22 | $0.00 10-K · filed 2023-02-22 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $0.00 derived: sum of 2 quarters · filed 2021-11-02 | $0.00 10-Q · filed 2021-11-02 | $4.34M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $0.00 10-Q · filed 2021-07-29 | $4.34M derived: sum of 3 quarters · filed 2023-02-22 | $8.63M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $0.00 10-Q · filed 2021-04-29 | $4.34M derived: sum of 2 quarters · filed 2023-02-22 | $8.63M derived: sum of 3 quarters · filed 2023-02-22 | $12.89M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $4.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $8.63M derived: sum of 2 quarters · filed 2023-02-22 | $12.89M derived: sum of 3 quarters · filed 2023-02-22 | $15.41M 10-K · filed 2023-02-22 |
| 2020-09-30 | $4.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $8.55M derived: sum of 2 quarters · filed 2021-11-02 | $11.07M 10-Q · filed 2021-11-02 | $11.07M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $4.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $6.78M 10-Q · filed 2021-07-29 | $6.78M derived: sum of 3 quarters · filed 2022-02-24 | $6.78M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $2.53M 10-Q · filed 2021-04-29 | $2.53M derived: sum of 2 quarters · filed 2022-02-24 | $2.53M derived: sum of 3 quarters · filed 2022-02-24 | $2.53M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-23 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $0.00 derived: sum of 2 quarters · filed 2019-02-26 | $0.00 derived: sum of 3 quarters · filed 2019-02-26 | $0.00 10-K · filed 2019-02-26 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $0.00 derived: sum of 2 quarters · filed 2017-10-26 | $0.00 10-Q · filed 2017-10-26 | $1.77M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $0.00 10-Q · filed 2017-07-26 | $1.77M derived: sum of 3 quarters · filed 2019-02-26 | $3.91M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $0.00 10-Q · filed 2017-04-26 | $1.77M derived: sum of 2 quarters · filed 2019-02-26 | $3.91M derived: sum of 3 quarters · filed 2019-02-26 | $6.01M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $3.91M derived: sum of 2 quarters · filed 2019-02-26 | $6.01M derived: sum of 3 quarters · filed 2019-02-26 | $8.07M 10-K · filed 2019-02-26 |
| 2016-09-30 | $2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $4.24M derived: sum of 2 quarters · filed 2017-10-26 | $6.30M 10-Q · filed 2017-10-26 | $8.34M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $4.17M 10-Q · filed 2017-07-26 | $6.21M derived: sum of 3 quarters · filed 2018-03-01 | $8.34M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $2.06M 10-Q · filed 2017-04-26 | $4.10M derived: sum of 2 quarters · filed 2018-03-01 | $6.23M derived: sum of 3 quarters · filed 2018-03-01 | $8.12M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $4.17M derived: sum of 2 quarters · filed 2018-03-01 | $6.05M derived: sum of 3 quarters · filed 2018-03-01 | $7.91M 10-K · filed 2018-03-01 |
| 2015-09-30 | $2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $4.01M derived: sum of 2 quarters · filed 2016-10-28 | $5.87M 10-Q · filed 2016-10-28 | $7.72M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $3.74M 10-Q · filed 2016-07-28 | $5.59M derived: sum of 3 quarters · filed 2017-02-23 | $7.42M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $1.86M 10-Q · filed 2016-04-27 | $3.71M derived: sum of 2 quarters · filed 2017-02-23 | $5.53M derived: sum of 3 quarters · filed 2017-02-23 | $7.30M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $3.67M derived: sum of 2 quarters · filed 2017-02-23 | $5.44M derived: sum of 3 quarters · filed 2017-02-23 | $7.10M 10-K · filed 2017-02-23 |
| 2014-09-30 | $1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $3.59M derived: sum of 2 quarters · filed 2015-11-04 | $5.26M 10-Q · filed 2015-11-04 | $6.85M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $3.43M 10-Q · filed 2015-07-31 | $5.03M derived: sum of 3 quarters · filed 2016-02-26 | $6.66M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $1.67M 10-Q · filed 2015-05-01 | $3.26M derived: sum of 2 quarters · filed 2016-02-26 | $4.90M derived: sum of 3 quarters · filed 2016-02-26 | $6.52M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $3.23M derived: sum of 2 quarters · filed 2016-02-26 | $4.85M derived: sum of 3 quarters · filed 2016-02-26 | $6.46M 10-K · filed 2016-02-26 |
| 2013-09-30 | $1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $3.25M derived: sum of 2 quarters · filed 2014-11-07 | $4.87M 10-Q · filed 2014-11-07 | $5.10M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $3.23M 10-Q · filed 2014-08-05 | $3.47M derived: sum of 3 quarters · filed 2015-02-27 | $5.26M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $1.61M 10-Q · filed 2014-05-01 | $1.85M derived: sum of 2 quarters · filed 2015-02-27 | $3.63M derived: sum of 3 quarters · filed 2015-02-27 | $6.60M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $236.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $2.02M derived: sum of 2 quarters · filed 2015-02-27 | $4.99M derived: sum of 3 quarters · filed 2015-02-27 | $8.52M 10-K · filed 2015-02-27 |
| 2012-09-30 | $1.79M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-10-30 | $4.76M derived: sum of 2 quarters · filed 2013-10-30 | $8.28M 10-Q · filed 2013-10-30 | $11.76M derived: sum of 4 quarters · filed 2014-06-20 |
| 2012-06-30 | $2.97M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-08-02 | $6.50M 10-Q/A · filed 2013-08-02 | $9.97M derived: sum of 3 quarters · filed 2014-06-20 | $13.46M derived: sum of 4 quarters · filed 2014-06-20 |
| 2012-03-31 | $3.53M 10-Q · filed 2013-05-02 | $7.00M derived: sum of 2 quarters · filed 2014-06-20 | $10.49M derived: sum of 3 quarters · filed 2014-06-20 | |
| 2011-12-31 | $3.47M derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-20 | $6.96M derived: sum of 2 quarters · filed 2014-06-20 | $10.59M 8-K · filed 2014-06-20 | |
| 2011-09-30 | $3.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $7.12M 10-Q · filed 2012-10-24 | ||
| 2011-06-30 | $3.63M 10-Q · filed 2012-07-31 | |||
| 2010-12-31 | $7.13M 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |